Preliminary efficacy of pharmacological treatments on sluggish cognitive tempo (cognitive disengagement syndrome)
A systematic review and meta-analysis
Datos Bibliográficos
| ID | 15519270 |
|---|---|
| Autores | Şenay Kılınçel (0000-0001-5298-0264, Istanbul Aydın University, autor de correspondencia), Furkan Bulut (Association of Child Psychotherapists), Pelin Göksel (Ondokuz Mayıs University), Miraç Barış Usta (0000-0002-1573-3165, American Academy of Child and Adolescent Psychiatry), Oğuzhan Kılınçel (0000-0003-2988-4631, İstanbul Gelişim Üniversitesi) |
| Año | 2026 |
| Volumen | 17 |
| Páginas | 1787612-1787612 |
| Fecha de publicación | 2026-03-12 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | Frontiers in Psychiatry (JOURNAL) |
| Identificadores de la revista | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Editorial | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2026.1787612 |
| PMID | 41908134 |
| OpenAlex | W7135101883 |
| Idioma | EN |
| Referencias citadas | 24 |
Preliminary evidence suggests that pharmacological treatments, particularly atomoxetine and methylphenidate, may be associated with moderate improvements in SCT/CDS symptoms. However, given the limited number of controlled trials and the heterogeneity in populations (e.g., ADHD with comorbid dyslexia), these findings should be considered exploratory. Further large-scale RCTs are necessary to confirm these results and establish personalized treatment protocols
Atomoxetine · Cognition · Disengagement theory · Meta-analysis · Population · Psychological intervention · Randomized controlled trial · Sample size determination · Attention Deficit Hyperactivity Disorder · Mind wandering and attention · Sleep and related disorders
| Velocidad de citación | historical |
|---|---|
| Altamente citado | No |